drugset
drugset / Trial / NCT06225492

DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands

NCT06225492 ↗

Phase 4 Completed 20 enrolled Main Line Center for Laser Surgery
RandomizedParallel-groupOpen-labelTreatment

Summary

This study seeks to evaluate the effectiveness and duration of action of DaxibotulinumtoxinA for neck rejuvenation through treatment of platysmal bands. This study will consist of one treatment visit with subjects being randomized to receiving 15 or 20 units of DaxibotulinumtoxinA per platysmal band. Subjects will return for 5 follow-up visits at 8, 12, 16, 20, and 24 weeks for evaluation.

Timeline

Start
2024-01-01
Primary completion
2025-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 15 iu —
Subject Botulinum toxin type A Protein / enzyme biologic 20 iu —

Indications

No indication recorded.